BEXSON
Live / Applied — Fourth extension granted (statement of use) (as of 10 Oct 2025)
What this means for you
Not registered yet, but its 08 Sept 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97583883
- Mark type
- Stylized text
- Filed
- 08 Sept 2022
- Published for opposition
- 15 Aug 2023
- Attorney of record
- Aaron D. Hendelman
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations for reducing, managing and relieving pain, treating addiction disorders and treating mental health illnesses; pharmaceutical preparations consisting of ketamine, flumazenil and psychedelics for the treatment of pain, addiction disorders and mental health illnesses; pharmaceutical preparations, namely, medicinal psychoactive psychedelic therapies for the treatment of pain, addiction disorders and mental health illnesses; drug delivery agents in the form of small molecules for the controlled release of therapeutic agents; wearable drug delivery devices, namely, subcutaneous pumps, sold filled with pharmaceutical preparations, for the delivery of medication for pain management, reduction and relief, addiction disorders, and mental health illnesses
- Class 010 — Medical apparatus: wearable drug delivery devices sold empty, namely, subcutaneous pumps for the delivery of medication for pain management, reduction and relief, addiction disorders, and mental health illnesses
- Class 035 — Advertising and business services: providing business information, advisory, and consultancy services relating to pharmaceuticals and drug delivery devices therefor
- Class 042 — Scientific and technological services: medical and scientific research in the fields of addiction disorders, mental health illnesses, pain management, reduction and relief; developing modular subcutaneous delivery platforms for small molecules for controlled delivery of therapeutic agents; medical and scientific research and development in relation to pharmaceuticals and drug delivery platforms; providing scientific information, advisory, and consultancy services relating to pharmaceuticals and drugy delivery devices therefor
- Class 044 — Medical, beauty and agricultural services: providing medical information, advisory, and consultancy services relating to pharmaceuticals and drug delivery devices therefor
- Class 045 — Legal and security services: providing regulatory compliance information, advisory, and consultancy services relating to pharmaceuticals and drug delivery devices therefor
Owner
- Bexson Biomedical, Inc., Santa Barbara, CA, US
- Bexson Biomedical, Inc., Santa Barbara, CA, US
Prosecution history
- 27 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 11 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Oct 2025 — SOU EXTENSION 4 GRANTED
- 10 Oct 2025 — SOU EXTENSION 4 FILED
- 10 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 09 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Apr 2025 — SOU EXTENSION 3 GRANTED
- 08 Apr 2025 — SOU EXTENSION 3 FILED
- 08 Apr 2025 — SOU TEAS EXTENSION RECEIVED
- 04 Oct 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Oct 2024 — SOU EXTENSION 2 GRANTED
- 04 Oct 2024 — SOU EXTENSION 2 FILED
- 04 Oct 2024 — SOU TEAS EXTENSION RECEIVED
- 16 Apr 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Apr 2024 — SOU EXTENSION 1 GRANTED